Prostate cancer cells need androgens (male hormones), like testosterone and dihydrotestosterone (DHT), to grow. Hormone therapy is a type of prostate cancer treatment that stops your body from making these hormones or letting them reach cancer cells. The cells then die or grow more slowly. It’...
Bertrand Tombal. (2012) Hormone Therapy for Prostate Cancer: What Have We Done With Charles Huggins’ Legacy?. European Urology 61 , 26-28 /Tombal B. Hormone therapy for prostate cancer: what have we done with Charles Huggins' legacy? Eur Urol 2012; 61: 26-8....
For the last six decades the standard palliative option for patients with advanced prostate cancer has centered on androgen deprivation strategies. The different approaches for achieving androgen deprivation, which include surgical castration or medical castration (oestrogen agonists, antiandrogens, LHRH ...
In 85% to 90% of cases of advanced prostate cancer, hormone therapy can shrink the tumor. However, hormone therapy for prostate cancer doesn't work forever. The problem is that not all cancer cells need hormones to grow. Over time, these cells that aren't reliant on hormones will spread...
If you or a loved one have been diagnosed with prostate cancer, you may be offered hormone therapy to treat it. Increasingly, hormone therapy is the treatment of choice, rather than surgery. Surgery to reduce hormone levels may only be offered if the can
(AP) -- A new study links hormone therapy for prostate cancer with a higher risk of death in older men who've had serious heart problems. Ad Hormone therapy suppresses the amount of testosterone produced, in turn causing prostate tumors to shrink or grow more slowly. The treatment, involving...
Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment Luteinizing hormone-releasing hormone (LHRH) analogues play a pivotal role in hormonal therapy regimens for the treatment of prostate cancer. Hormonal ther... H Akaza - 《Pharmacology》 被引量: 40发表: ...
Prostate cancerRadiorecurrenceHormone therapyIndustry SectorsBiotechnologyHealth &HospitalsPharmaBACKGROUND: The management of patients who relapse after radical radiotherapy is a challenging problem for the multidisciplinary team. This group of men may have been considered ineligible or chosen not to be ...
这是被批准用于治疗激素抵抗性前列腺癌(hormone refractory prostate cancer)的首个药物。该药已显示出有促进患者生存的 … www.oneyao.net|基于10个网页 2. 激素非依赖性前列腺癌 ... )hormone refractory prostate cancer激素非依赖性前列腺癌) androgen-dependence prostate cancer 雄激素依赖性前列腺癌 ... ...
Orgovyx (relugolix) is now approved to treat advanced prostate cancer and is the first oral hormone therapy approved for this indication, the U.S. Food and Drug Administration announced Friday. As opposed to currently approved hormone therapies that are injected or placed as implants under the ...